ARWR

Arrowhead Pharmaceuticals, Inc.

Healthcare›Biotechnology|NASDAQ Global Select|US

Price

$61.03

Market Cap

$8.55B

Beta

1.30

P/E

39.7

Div Yield

—

Sector Median P/E

22.6

Key Metrics

Revenue Growth (YoY)+4081.77%

EPS Growth (YoY)+129.67%

Revenue CAGR 3Y+57.67%

P/E Ratio39.7

PEG Ratio0.31

FCF Yield+3.77%

Debt / Equity0.55

Interest Coverage3.3x

No credit card required

Already have an account? Sign in to view the full analysis for ARWR.